ArticleActa pharmaceutica Sinica. B2023

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection.

Xintong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.